| Literature DB >> 36160095 |
Seyed Mohamadmehdi Moshtaghion1, Mohammad Abolhosseini1, Bahareh Kheiri2, Mohammad Ali Javadi2,3, Leila Ziaee Ardakani4, Mozhgan Rezaei Kanavi1,3.
Abstract
Purpose: To report eye bank records for pediatric keratoplasty in Iran between 2006 and 2019.Entities:
Keywords: Descemet Membrane Stripping Automated Endothelial Keratoplasty; Keratoconus; Pediatric Keratoplasty; Penetrating Keratoplasty; Deep Anterior Lamellar Keratoplasty
Year: 2022 PMID: 36160095 PMCID: PMC9493424 DOI: 10.18502/jovr.v17i3.11569
Source DB: PubMed Journal: J Ophthalmic Vis Res ISSN: 2008-322X
Indications for pediatric keratoplasty in Iran between 2006 and 2019 and the corresponding distribution in two age groups of 12 and 12 years.
|
| ||||
|
| ||||
|
| 12 | |||
| Mean age | 11.2 | 7.5 | 14.5 |
|
|
|
|
|
|
|
| Keratoconus | 958 (58.0%) | 235 (33.4%) | 723 (76.3%) |
|
| Aphakic/Pseudophakic bullous keratopathy | 258 (15.6%) | 171 (24.3%) | 87 (9.2%) |
|
| Non-specified corneal opacities | 244 (14.8%) | 161 (22.9%) | 83 (8.8%) |
|
| Corneal infections | 179 (10.8%) | 128 (18.2%) | 51 (5.4%) |
|
| | 27 (15.1%) | 15 (11.7%) | 12 (23.5%) | 0.057 |
| | 61 (34.1%) | 42 (32.8%) | 19 (37.3%) | 0.573 |
| | 13 (7.3%) | 9 (7%) | 4 (7.8%) | 0.831 |
| | 0 (0%) | 0 (0%) | 0 (0%) | N/A |
| | 78 (43.6%) | 62 (48.4%) | 16 (31.4%) | 0.038 |
| Corneal degenerations | 12 (0.7%) | 8 (1.1%) | 4 (0.4%) | 0.223 |
|
|
|
|
|
|
| Corneal dystrophies | 188 (67.9%) | 129 (65.8%) | 59 (72.8%) |
|
| | 146 (77.7%) | 117 (90.7%) | 29 (49.2%) |
|
| | 24 (12.7%) | 5 (3.9%) | 19 (32.2%) |
|
| | 13 (6.9%) | 3 (2.3%) | 10 (16.9%) |
|
| | 3 (1.6%) | 3 (2.3%) | 0 (0%) | 0.320 |
| | 2 (1.1%) | 1 (0.8%) | 1 (1.7%) | 0.627 |
| Congenital corneal opacity | 89 (32.1%) | 67 (34.2%) | 22 (27.2%) |
|
| | 41 (46.1%) | 35 (52.2%) | 6 (27.3%) | 0.023 |
| | 25 (28.1%) | 14 (20.9%) | 11 (50%) | 0.005 |
| | 10 (11.2%) | 6 (9%) | 4 (18.2%) | 0.121 |
| | 9 (10.1%) | 9 (13.4%) | 0 (0%) | 0.128 |
| | 4 (4.5%) | 3 (4.5%) | 1 (4.5%) | 0.494 |
|
|
|
|
|
|
| Mechanical injuries | 40 (58.0%) | 29 (65.9%) | 11 (44.0%) | 0.003 |
| Chemical injuries | 29(42.0%) | 15 (34.1%) | 14 (56.0%) | 0.746 |
|
|
|
|
|
|
| Total | 2178 (100.0%) | 1061 (100.0%) | 1117 (100.0%) | 0.09 |
| CHED, congenital hereditary endothelial dystrophy; MCD, macular corneal dystrophy; GCD, granular corneal dystrophy; LCD, lattice corneal dystrophy | ||||
Number of surgical techniques used for pediatric keratoplasty between 2006 and 2019, and the corresponding distribution in two age groups of 12 and 12 years.
|
| |||||
|
| |||||
| PKP | 1981 (90.9%) | 998 (94.1%) | 983 (88.0%) | 0.634 | |
| DALK | 159 (7.3%) | 38 (3.6%) | 121 (10.8%) |
| |
| DSAEK | 24 (1.1%) | 19 (1.8%) | 5 (0.4%) | 0.002 | |
| ALK | 10 (0.5%) | 3 (0.3%) | 7 (0.6%) | 0.082 | |
| KLAL | 4 (0.2%) | 3 (0.3%) | 1 (0.1%) | 0.178 | |
|
|
|
|
|
| |
| PKP, penetrating keratoplasty; DALK, deep anterior lamellar keratoplasty; DSAEK, Descemet stripping automated endothelial keratoplasty; ALK, anterior lamellar keratoplasty; KLAL, keratolimbal allograft | |||||
Publications on pediatric keratoplasty since 1968, in the developed and developing countries including the present study.
|
| ||||||||||||||
|
|
|
|
| |||||||||||
| Developing Countries | Iran/2006-2019 | 2178/2050 | 1651 (75.8%) | 958 (44%) | 258 (11.9%) | 244 (11.2%) | 179 (8.2%) | 12 (0.6%) | 277 (12.7%) | 188/146/42(8.6%/ 6.7%/1.9%) | 0 | 69 (3.2%) | 181 (8.3%) | 2178 (100%) |
| Brazil/2019 | 51/43 | 9 (17.7%) | N/S | N/S | N/S | 9 (17.7%) | N/S | 37 (72.6%) | 8/8/N/S(15.7%/8%) | 29 (56.9%) | 5 (9.8%) | N/S | 51 (100%) | |
| Eastern China/2008-2017 | 1059/1026 | 175 (16.5%) | 118 (11.1%) | 5 (0.5%) | 24 (2.3%) | 26 (2.5%) | 2 (0.2%) | 790 (74.6%) | 8/ N/S / N/S (0.8%) | 782 (73.8%) | 38 (3.6%) | 56 (5.3%) | 1059 (100%) | |
| Malaysia/2008-2017 | 16/14 | 10 (62.5%) | N/S | N/S | 1 (6.3%) | 9 (56.3%) | N/S | 3 (18.8%) | N/S | 3 (18.8%) | 2 (12.5%) | 1 (6.3%) | 16 (100%) | |
| Mexico/1995-2011 | 574/(N/S) | 461 (80.3%) | 319 (55.6%) | 35 (6.1%) | 19 (3.3%) | 88 (15.3%) | N/S | 70 (12.2%) | N/S | 70 (12.2%) | 43 (7.5%) | N/S | 574 (100%) | |
| India/2007-2011 | 66/66 | 33 (50%) | N/S | N/S | N/S | 22 (33.3%) | 11 (16.7%) | 24 (36.4%) | 18/6/12 (27.3%/9.1%/18.2%) | 6 (9.1%) | 5 (7.6%) | 4 (6.1%) | 66 (100%) | |
| Tunisia/2003-2008 | 16/15 | 8 (50%) | 5 (31.3%) | N/S | N/S | 3 (18.8%) | N/S | 2 (12.5%) | 1/ N/S / N/S (6.3%) | 1 (6.3%) | 6 (37.5%) | N/S | 16 (100%) | |
| China (Shanghai)/2003-2007 | 156/149 | 71 (45.5%) | 17 (10.9%) | N/S | 8 (5.1%) | 46 (29.5%) | N/S | 37 (23.7%) | 7/7/ N/S (4.5%/4.5%) | 30 (19.2%) | 48 (30.8%) | N/S | 156 (100%) | |
| North China/1994-2005 | 410/371 | 148 (36.1%) | 37 (9%) | N/S | 11 (2.7%) | 93 (22.7%) | 7 (1.7%) | 112 (27.3%) | 29/ N/S / N/S (7.1%) | 83 (20.2%) | 150 (36.6%) | N/S | 410 (100%) | |
| Saudi Arabia/1990-2003 | 165/134 | 18 (10.9%) | N/S | N/S | N/S | 18 (10.9%) | N/S | 130 (78.8%) | 35/35/ N/S (21.2%) | 95 (57.6%) | 17 (10.3%) | N/S | 165 (100%) | |
| India/1998-2004 | 168/154 | 89 (53%) | N/S | 2 (1.2%) | N/S | 73 (43.5%) | 14 (8.3%) | 57 (33.9%) | 14/ N/S / N/S (8.3%) | 43 (25.6%) | 22 (13.1%) | N/S | 168 (100%) | |
| India/1988-1995 | 162/140 | 85 (52.5%) | N/S | N/S | 31 (19.1%) | 54 (33.3%) | N/S | 47 (29%) | 20/20/ N/S (12.4%/12.4%) | 27 (16.7%) | 22 (13.6%) | 8 (4.9%) | 162 (100%) | |
| Developed Countries | USA/2005-2017 | 2620/(N/S) | 1931 (73.7%) | 883 (33.7%) | 118 (4.5%) | 836 (31.9%) | 94 (3.6%) | N/S | 419 (16%) | 262/58/204 (10%/2.2%/7.8%) | 157 (%6) | 79 (3%) | 191 (7.3%) | 2620 (100%) |
| Finland/1968-2011 | 39/(N/S) | 16 (41%) | 7 (18%) | N/S | 7 (18%) | 1 (2.6%) | 1 (2.6%) | 12 (30.8%) | 4/ N/S / N/S (10.3%) | 8 (20.5%) | 11 (28.2%) | N/S | 39 (100%) | |
| Italy/2010-2013 | 54/43 | 30 (55.6%) | 20 (37%) | 2 (3.7%) | 6 (11.1%) | 2 (3.7%) | N/S | 13 (24.1%) | N/S | 13 (24.1%) | 6 (11.1%) | 5 (9.3%) | 54 (100%) | |
| Singapore/1991-2011 | 105/105 | 58 (45.7%) | 15 (11.8%) | 5 (3.9%) | 26 (20.5%) | 12 (9.5%) | N/S | 45 (35.4%) | 2/1/1 (1.6%/0.8%/0.8%) | 43 (33.9%) | 2 (1.6%) | 22 (17.3%) | 127 (100%) | |
| Denmark/1968-2008 | 63/60 | 38 (52.1%) | 12 (16.4%) | N/S | 5 (6.8%) | 21 (28.8%) | N/S | 13 (17.8%) | N/S | 13 (17.8%) | 9 (12.3%) | 13 (17.8%) | 73 (100%) | |
| USA (California)/1991-2006 | 60/47 | 13 (12.3%) | 2 (1.9%) | N/S | N/S | 11 (10.4%) | N/S | 37 (34.9%) | 7/7/ N/S (6.6%/6.6%) | 30 (28.3%) | 10 (9.4%) | 46 (43.4%) | 106 (100%) | |
| New Zealand/1991-2003 | 58/52 | 43 (74.1%) | 39 (67.2%) | N/S | N/S | 4 (6.9%) | N/S | 9 (15.5%) | 7/2/5 (12.1%/3.5%/8.6%) | 2 (3.5%) | 6 (10.3%) | N/S | 58 (100%) | |
| Australia/1984-2002 | 19/16 | 0 (0%) | N/S | N/S | N/S | N/S | N/S | 8 (42.1%) | 2/1/1 (10.5%/5.3%/5.3%) | 6 (31.6%) | 11 (57.9%) | N/S | 19 (100%) | |
| white<bcol>15</ecol>CHED, congenital hereditary endothelial dystrophy | ||||||||||||||